Heeh-Young Lee
Founder at Lumebio, Inc.
Net worth: 46 877 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Ng | M | 49 |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | 5 years |
| Dorman Followwill | M | 60 | 7 years | |
| Allan Camaisa | M | - |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | 7 years |
| Alexis Nahama | M | - | 7 years | |
| John B. Ramil | M | 68 |
University of South Florida
| 23 years |
| David Lemus | M | 61 | 7 years | |
| Yue Wu | M | 62 | 8 years | |
| Myoung Ho Jang | M | - |
GI CELL Co. Ltd.
 GI CELL Co. Ltd. BiotechnologyHealth Technology GI CELL Co. Ltd. develops cell therapeutics. The company is based in Seongnam, South Korea. The South Korean company was founded in 2018 by Myoung Ho Jang. The CEO is Chun Pyo Hong. | 6 years |
| Byeong Cho Min | M | - |
GI CELL Co. Ltd.
GI CELL Co. Ltd. BiotechnologyHealth Technology GI CELL Co. Ltd. develops cell therapeutics. The company is based in Seongnam, South Korea. The South Korean company was founded in 2018 by Myoung Ho Jang. The CEO is Chun Pyo Hong. | - |
| Stuart M. Brooks | M | 87 |
University of South Florida
| 26 years |
| Carl P. Carlucci | M | 75 |
University of South Florida
| 23 years |
| Hector J. Gomez | M | 85 |
University of South Florida
| 25 years |
| James Schoeneck | M | 66 |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | 4 years |
| Mark R. Brunswick | M | - | 7 years | |
| Scott Leftwich | M | - |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | 5 years |
| Chun Pyo Hong | M | - |
GI CELL Co. Ltd.
GI CELL Co. Ltd. BiotechnologyHealth Technology GI CELL Co. Ltd. develops cell therapeutics. The company is based in Seongnam, South Korea. The South Korean company was founded in 2018 by Myoung Ho Jang. The CEO is Chun Pyo Hong. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas J. Langston | M | 63 | 3 years | |
| Jenny Bloem | F | - |
University of South Florida
| 4 years |
| Robert Knight | M | 73 | 3 years | |
| Jerome Zeldis | M | 74 | 3 years | |
| Douglas O. Ebersole | M | 68 | 2 years | |
| Kevin Patrick Vanclevep | M | - |
University of South Florida
| 4 years |
| Kevin Herde | M | 53 | 1 years | |
| Gary Sarkissian | M | - |
University of South Florida
| 2 years |
| Sean Loughran | M | - |
University of South Florida
| 4 years |
| Liz Nicholas | F | - |
University of South Florida
| 2 years |
| Kelly Aldridge | M | - |
University of South Florida
| 3 years |
| Scot L. Johnson | M | 48 |
University of South Florida
| 4 years |
| Paul Gargagliano | M | - |
University of South Florida
| 4 years |
| Justin Langley | M | - |
University of South Florida
| 4 years |
| Jeff Fettes | M | - |
University of South Florida
| 3 years |
| Zhenwei Miao | M | 60 | 3 years | |
| Andrew W. Koebel | M | - |
University of South Florida
| 4 years |
| Brian Lee McMillin | M | - |
University of South Florida
| 4 years |
| Jeffrey Su | M | - | 2 years | |
| Xiao Feng Cheng | M | 49 |
University of South Florida
| 2 years |
| Dean Ferrigno | M | 60 | - | |
| Gokce Tezel | M | 50 |
University of South Florida
| 2 years |
| Bassam Abdulaziz Noor | M | - |
University of South Florida
| 4 years |
| Shi Wei Liu | M | 53 |
University of South Florida
| 1 years |
| Hui Li | M | - | - | |
| Stephen L Klincewicz | M | - | 3 years | |
| Thomas McCrimmon | M | 50 |
University of South Florida
| 6 years |
| Robert D. Allison | M | 49 |
University of South Florida
| 1 years |
| Maggie Philbin | F | - |
University of South Florida
| 2 years |
| Michele Batz | F | - |
University of South Florida
| 4 years |
| Wei Qian | M | 67 |
University of South Florida
| 6 years |
| Christie Britt | F | - |
University of South Florida
| 2 years |
| Jeff Detwiler | M | - |
University of South Florida
| 4 years |
| Kathy Hartley | F | - |
University of South Florida
| 4 years |
| Betsy G. Pecor | F | 58 |
University of South Florida
| 2 years |
| Chad Wilton Fugere | M | - |
University of South Florida
| 4 years |
| Thomas McCrimmon | M | 50 |
University of South Florida
| 4 years |
| Jiong Shao | M | 55 | 2 years | |
| Alfonso Zulueta | M | 61 |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | - |
| Mike Smith | M | - |
University of South Florida
| 4 years |
| Allen Krantz | M | - |
University of South Florida
| 3 years |
| Michael R. Piazza | M | - |
University of South Florida
| 1 years |
| Michael Babb | M | - |
University of South Florida
| 1 years |
| John W. Hadden | M | - |
University of South Florida
| 18 years |
| Chris Thornsberry | M | - |
University of South Florida
| 4 years |
| Samuel H. Sutherland | M | - |
University of South Florida
| 2 years |
| Jason T. Gaskill | M | - |
University of South Florida
| 4 years |
| Tanya Towne | F | - |
University of South Florida
| 4 years |
| Ben Forlaw | M | - |
University of South Florida
| 4 years |
| Lauren Cowart McAnany | F | - |
University of South Florida
| 4 years |
| Scott Jorgensen | M | 61 |
University of South Florida
| 3 years |
| Miranda Toledano | F | 47 | 1 years | |
| John Liatos | M | 56 | 1 years | |
| Susan LeFrancois | M | - |
University of South Florida
| 4 years |
| Caleb Fritz | M | - |
University of South Florida
| 4 years |
| Bruce McVey | M | - |
University of South Florida
| 2 years |
| Christina M. Calhoun | F | - |
University of South Florida
| 4 years |
| William S. Dalton | M | - |
University of South Florida
| 2 years |
| Stephen Thesing | M | - |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | - |
| Yorlan Alfonso | M | - |
University of South Florida
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 73 | 96.05% |
| South Korea | 3 | 3.95% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Heeh-Young Lee
- Personal Network
